Seongnam, South Korea

Seul-Ae Lee

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Dae Hwa Pharma. Co., Ltd.. Active years: 2020-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seul-Ae Lee. Retrieved from https://idiyas.com/inventor/seul-ae-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Seul-Ae Lee: Innovator in Pharmaceutical Composition

Introduction

Seul-Ae Lee is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for oral administration.

Latest Patents

Seul-Ae Lee holds two patents, both focusing on pharmaceutical compositions that include taxanes. His latest patents provide a detailed formulation that includes a taxane, a medium chain triglyceride, and an oleoyl glycerol complex with specific weight percentages of monooleoyl, dioleoyl, and trioleoyl glycerol contents. Additionally, these compositions may include a surfactant and optionally a polyoxyl glyceryl fatty acid ester, along with a process for preparing the same.

Career Highlights

Seul-Ae Lee is currently employed at Dae Hwa Pharma Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing oral drug delivery systems, which are crucial for improving patient compliance and therapeutic efficacy.

Collaborations

Some of his notable coworkers include In-Hyun Lee and Min-Hee Son, who contribute to the collaborative environment at Dae Hwa Pharma Co., Ltd. Their teamwork fosters innovation and enhances the development of new pharmaceutical solutions.

Conclusion

Seul-Ae Lee's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative work continues to impact the field positively, paving the way for future developments in drug formulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…